CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, 1952
N. diseases: 63; N. variants: 20
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.752 | 0.240 | 1 | 109275908 | downstream gene variant | C/T | snv | 0.74 |
|
Cardiovascular Diseases | 0.830 | 1.000 | 7 | 2011 | 2016 | |||||||
|
0.851 | 0.040 | 1 | 109274968 | 3 prime UTR variant | G/T | snv | 0.22 |
|
Cardiovascular Diseases | 0.810 | 1.000 | 3 | 2011 | 2018 | |||||||
|
0.752 | 0.240 | 1 | 109275908 | downstream gene variant | C/T | snv | 0.74 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.810 | 1.000 | 2 | 2009 | 2012 | |||||||
|
0.752 | 0.240 | 1 | 109275908 | downstream gene variant | C/T | snv | 0.74 |
|
0.800 | 1.000 | 12 | 2008 | 2019 | ||||||||
|
0.851 | 0.040 | 1 | 109274968 | 3 prime UTR variant | G/T | snv | 0.22 |
|
0.800 | 1.000 | 11 | 2008 | 2019 | ||||||||
|
0.851 | 0.040 | 1 | 109274968 | 3 prime UTR variant | G/T | snv | 0.22 |
|
0.800 | 1.000 | 8 | 2012 | 2019 | ||||||||
|
0.752 | 0.240 | 1 | 109275908 | downstream gene variant | C/T | snv | 0.74 |
|
0.800 | 1.000 | 8 | 2009 | 2019 | ||||||||
|
1 | 109275216 | 3 prime UTR variant | T/C | snv | 0.75 |
|
0.800 | 1.000 | 8 | 2008 | 2019 | ||||||||||
|
0.851 | 0.120 | 1 | 109275684 | 3 prime UTR variant | G/T | snv | 0.74 |
|
0.800 | 1.000 | 7 | 2008 | 2019 | ||||||||
|
0.851 | 0.120 | 1 | 109275684 | 3 prime UTR variant | G/T | snv | 0.74 |
|
0.800 | 1.000 | 7 | 2010 | 2019 | ||||||||
|
0.851 | 0.080 | 1 | 109274570 | 3 prime UTR variant | A/G | snv | 0.23 |
|
0.800 | 1.000 | 6 | 2012 | 2019 | ||||||||
|
0.851 | 0.080 | 1 | 109274570 | 3 prime UTR variant | A/G | snv | 0.23 |
|
0.800 | 1.000 | 5 | 2012 | 2019 | ||||||||
|
0.752 | 0.240 | 1 | 109275908 | downstream gene variant | C/T | snv | 0.74 |
|
0.800 | 1.000 | 4 | 2012 | 2019 | ||||||||
|
1 | 109264661 | intron variant | A/C;T | snv | 4.0E-06; 0.10 |
|
0.800 | 1.000 | 4 | 2008 | 2019 | ||||||||||
|
1.000 | 0.040 | 1 | 109272630 | non coding transcript exon variant | A/G | snv | 0.28 | 0.32 |
|
0.800 | 1.000 | 3 | 2008 | 2018 | |||||||
|
0.851 | 0.120 | 1 | 109275684 | 3 prime UTR variant | G/T | snv | 0.74 |
|
0.800 | 1.000 | 3 | 2012 | 2018 | ||||||||
|
1 | 109275216 | 3 prime UTR variant | T/C | snv | 0.75 |
|
0.800 | 1.000 | 3 | 2012 | 2019 | ||||||||||
|
1 | 109264661 | intron variant | A/C;T | snv | 4.0E-06; 0.10 |
|
0.800 | 1.000 | 3 | 2012 | 2019 | ||||||||||
|
0.851 | 0.080 | 1 | 109274570 | 3 prime UTR variant | A/G | snv | 0.23 |
|
0.800 | 1.000 | 3 | 2012 | 2019 | ||||||||
|
0.851 | 0.040 | 1 | 109274968 | 3 prime UTR variant | G/T | snv | 0.22 |
|
0.800 | 1.000 | 2 | 2012 | 2018 | ||||||||
|
0.851 | 0.120 | 1 | 109275684 | 3 prime UTR variant | G/T | snv | 0.74 |
|
0.800 | 1.000 | 2 | 2009 | 2016 | ||||||||
|
0.851 | 0.120 | 1 | 109275684 | 3 prime UTR variant | G/T | snv | 0.74 |
|
Cardiovascular Diseases | 0.800 | 1.000 | 2 | 2012 | 2016 | |||||||
|
0.752 | 0.240 | 1 | 109275908 | downstream gene variant | C/T | snv | 0.74 |
|
Cardiovascular Diseases | 0.720 | 1.000 | 3 | 2014 | 2019 | |||||||
|
0.851 | 0.040 | 1 | 109274968 | 3 prime UTR variant | G/T | snv | 0.22 |
|
Cardiovascular Diseases | 0.710 | 1.000 | 3 | 2018 | 2018 | |||||||
|
0.752 | 0.240 | 1 | 109275908 | downstream gene variant | C/T | snv | 0.74 |
|
0.700 | 1.000 | 6 | 2008 | 2013 |